Clinical Studies & Resources
Salonpas® allocates significant resources to clinical study and product innovation that keeps us aligned to the needs of pain sufferers and the professional guidance that recommends a “topicals first” approach to pain management.
Clinical Studies of Salonpas® Products
Higashi Study
From a randomized, double-blind, parallel-group, placebo-controlled, multicenter study forming the basis of our New Drug Application approval.
RELIEF Study
Observational study of benefits of Salonpas® Pain Relieving Patch on pain intensity, use of concurrent oral medications and BPI scores.
AI Study
Applying artificial intelligence (AI) to patient profile reveals which ones could benefit most from Salonpas®.
Treatment Guidelines
CDC
In response to the opioid crisis, the CDC released importance guidance for the use of topical analgesics as first line medicine.
ACP & AAFP
These two academies released guidance that recommends a “topical NSAIDs first approach” for acute non-low back musculoskeletal pain.
Additional Information on Topical Analgesics
Dr. Gudin Q&A
Esteemed doctor and Salonpas® Advisor shares his insights.
#1 Doctor Recommended
If you’re recommending Salonpas® to your patients, you’re in good company.